CNR Institutional Research Information System

MORONI, ELISABETTA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.454
NA - Nord America 910
EU - Europa 464
SA - Sud America 297
Continente sconosciuto - Info sul continente non disponibili 168
AF - Africa 25
OC - Oceania 2
Totale 3.320
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 856
SG - Singapore 624
CN - Cina 301
BR - Brasile 237
IT - Italia 206
HK - Hong Kong 173
VN - Vietnam 145
FR - Francia 80
KR - Corea 53
FI - Finlandia 37
IN - India 36
NL - Olanda 31
DE - Germania 29
AR - Argentina 28
JP - Giappone 27
BD - Bangladesh 23
CA - Canada 19
GB - Regno Unito 19
MX - Messico 14
ZA - Sudafrica 11
ID - Indonesia 9
IL - Israele 9
CO - Colombia 8
IQ - Iraq 7
PL - Polonia 7
EC - Ecuador 6
ES - Italia 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
IE - Irlanda 5
PE - Perù 5
TR - Turchia 5
AL - Albania 4
CL - Cile 4
JM - Giamaica 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
UA - Ucraina 4
UZ - Uzbekistan 4
BB - Barbados 3
BE - Belgio 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
MY - Malesia 3
NI - Nicaragua 3
NP - Nepal 3
PY - Paraguay 3
SE - Svezia 3
TN - Tunisia 3
VE - Venezuela 3
BO - Bolivia 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
LK - Sri Lanka 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MF - Saint Martin 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.152
Salva come PNG Salva come JPEG
Città #
Singapore 358
Santa Clara 313
Hong Kong 170
Hefei 130
Ashburn 96
San Jose 83
Milan 66
Lauterbourg 65
Beijing 56
Seoul 53
Ho Chi Minh City 48
Los Angeles 48
Dallas 35
Hanoi 34
Lappeenranta 23
Brescia 20
São Paulo 16
Tokyo 15
Mumbai 12
Rio de Janeiro 11
Alzano Lombardo 10
Buffalo 10
Johannesburg 10
New York 10
Da Nang 9
Frankfurt am Main 9
Minamishinagawa 8
Montreal 8
Nuremberg 8
Council Bluffs 7
Florence 7
Helsinki 7
Padova 7
Trieste 7
Turku 7
Curitiba 6
Belo Horizonte 5
Bengaluru 5
Campinas 5
Chennai 5
Chicago 5
Denver 5
Houston 5
Phoenix 5
Warsaw 5
Amsterdam 4
Brasília 4
Brooklyn 4
Buenos Aires 4
Cirimido 4
Colombo 4
Falkenstein 4
Guangzhou 4
Guarulhos 4
Haiphong 4
Hải Dương 4
Lima 4
London 4
Mexico City 4
Pelotas 4
Porto Alegre 4
Tashkent 4
Atlanta 3
Bergamo 3
Biên Hòa 3
Bologna 3
Bridgetown 3
Brussels 3
Dhaka 3
Dublin 3
Kingston 3
Managua 3
Manaus 3
Miami 3
Ninh Bình 3
Orem 3
Osaka 3
Quito 3
Quận Một 3
Riyadh 3
Rome 3
San Francisco 3
San José 3
Scandicci 3
Shenzhen 3
Sorrento 3
The Bronx 3
Toronto 3
Vienna 3
Abbeville 2
Addis Ababa 2
Agawam 2
Aracaju 2
Arese 2
Athens 2
Baghdad 2
Balch Springs 2
Barquisimeto 2
Blumenau 2
Bogotá 2
Totale 1.998
Salva come PNG Salva come JPEG
Nome #
Design and Test of Molecules that Interfere with the Recognition Mechanisms between the SARS-CoV-2 Spike Protein and Its Host Cell Receptors 111
Point mutations of the mitochondrial chaperone TRAP1 affect its functions and pro-neoplastic activity 89
Conformational Dynamics of hAgo2 Silencing: Decoding Functional Divergence across Human Argonaute Paralogs 83
Frontiers and Challenges of Computing ncRNAs Biogenesis, Function and Modulation 82
Target oriented-drug discovery: unraveling the molecular interaction between Leishmania Hsp90 and a celastrol carboxamide derivative 79
The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein 71
Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design 68
Visualizing the Dynamics of a Protein Folding Machinery: The Mechanism of Asymmetric ATP Processing in Hsp90 and its Implications for Client Remodelling 66
Design of allosteric stimulators of the HSP90 ATPase as novel anticancer leads 64
N-Glycosylation-Induced Pathologic Protein Conformations as a Tool to Guide the Selection of Biologically Active Small Molecules 62
Integrating Protein Interaction Surface Prediction with a Fragment-Based Drug Design: Automatic Design of New Leads with Fragments on Energy Surfaces 61
HIF1alfa-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia 60
Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1 60
Insights from molecular dynamics simulations for the development of modulators of mitochondrial Hsp90 (Trap1) activity 59
How aberrant N-glycosylation can alter protein functionality and ligand binding: An atomistic view 59
Transcription factor protein interactomes reveal genetic determinants in heart disease 58
Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II 56
Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1 54
Design and synthesis of cyclic peptides targeting Gas6 53
N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease 52
Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1 51
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 50
Conformational Behavior of SARS-Cov-2 Spike Protein Variants: Evolutionary Jumps in Sequence Reverberate in Structural Dynamic Differences 47
Atomistic Simulations of the Mechanisms of the Poorly Catalytic Mitochondrial Chaperone Trap1: Insights into the Effects of Structural Asymmetry on Reactivity 47
Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical Probes 46
Investigating Dynamic and Energetic Determinants of Protein Nucleic Acid Recognition: Analysis of the Zinc Finger Zif268-DNA Complexes 45
Studying the Dynamics of a Complex G-Quadruplex System: Insights into the Comparison of MD and NMR Data 45
Allosteric Regulation Points Control the Conformational Dynamics of the Molecular Chaperone Hsp90 45
Disulfide-mediated tetramerization of TRAP1 fosters its antioxidant and pro-neoplastic activities 42
The Dynamics of the Folding Machinery 42
A Fe2+-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes 42
Advancing Molecular Simulations: Merging Physical Models, Experiments, and AI to Tackle Multiscale Complexity 41
Machine Learning Prediction of Allosteric Drug Activity from Molecular Dynamics 41
Arrestins as Possible Drug Targets 41
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization. 41
Structural determinants of cold activity and glucose tolerance of a family 1 glycoside hydrolase (GH1) from Antarctic Marinomonas sp. ef1 39
Expedient Access to 2-Benzazepines by Palladium-Catalyzed C-H Activation: Identification of a Unique Hsp90 Inhibitor Scaffold 38
Evaluation of docking procedures reliability in affitins-partners interactions 38
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 37
molecular dynamics simulations reveal the mechanisms of allosteric activation of Hsp90 by designed ligands 37
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern 37
Molecular structure and enzymatic mechanism of the human collagen hydroxylysine galactosyltransferase GLT25D1/COLGALT1 37
Cracking the chaperone code through the computational microscope 36
A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein 35
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors 34
Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives 34
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 33
Novel PARP-1 Inhibitor scaffolds disclosed by a dynamic structure-based pharmacophore approach 32
Exploiting conformational dynamics in drug discovery: Design of C-terminal inhibitors of Hsp90 with improved activities 32
MM/PBSA analysis of molecular dynamics simulations of bovine beta-lactoglobulin: free energy gradients in conformational transitions? 31
Computational approaches meet experiments to design new allosteric ligands 31
Structures, dynamics, complexes, and functions: From classic computation to artificial intelligence 31
The Structural Asymmetry of Mitochondrial Hsp90 (Trap1) Determines Fine Tuning of Functional Dynamics 31
Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography 29
Dynamic-based discovery of new allosteric ligands targeting the Hsp90 C-terminal inhibitor binding site 29
Investigating dynamic and energetic determinants of protein nucleic acid recognition: Analysis of the zinc finger zif268-DNA complexes 29
Second generation of fucose-based DC-SIGN ligands: Affinity improvement and specificity versus Langerin 29
Identification of DNA-binding protein target sequences by physical effective energy functions: Free energy analysis of lambda repressor-DNA complexes 29
The Dynamics of Drug Discovery 29
Conformational regulation of Hsp90 through mutation and small molecules 29
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 28
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation 28
Conformational regulation of Hsp90 though mutations and small molecules 28
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy 28
Molecular dynamics simulations of hsp90 with an eye to inhibitor design. 27
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors 27
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation 27
Using QM/MM Molecular Dynamics to Model Reactivity in the mitochondrial Chaperone Trap1 26
Chemical and Biophysical Approaches to Allosteric Modulation 26
Assessment of Mutational Effects on Peptide Stability through Confinement Simulations 26
Impact of Mutations on NPAC Structural Dynamics: Mechanistic Insights from MD Simulations 25
Synthesis of Functionalized 2-(4-Hydroxyphenyl)-3-methylbenzofuran Allosteric Modulators of Hsp90 Activity 25
3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues 24
Identification of a new scaffold for Hsp90 C-terminal inhibition 24
Modifying Hsp90 dynamics and functional relationships through rationally designed allosteric activators 24
Structure and sequence determinants of aggregation investigated with molecular dynamics 21
Structure and sequence determinants of aggregation investigated with molecular dynamics 21
Activation of Hsp90 activity and conformational dynamics through computationally designed allosteric ligands: functional implications 21
Investigating allostery with atomistic biomolecular simulations 17
Selective allosteric regulation of Leishmania braziliensis Hsp90 through a parasite-specific regulatory hub 8
Totale 3.320
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.686
article - articoli 10.188
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 45
Totale 21.919
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202413 0 0 0 0 0 0 0 0 1 2 0 10
2024/20251.405 2 3 70 54 250 201 43 117 31 66 298 270
2025/20261.790 108 172 196 290 328 62 290 75 57 97 74 41
2026/2027112 112 0 0 0 0 0 0 0 0 0 0 0
Totale 3.320